Figure S1. Details of human sperm capture panel and comparisons to other commercially available assays. A) Chromosomal ideogram of targeted regions found in the human sperm capture panel. B) Intersection of common CpGs from the different assays. C) Distribution by genomic regions (top) and CpG islands (bottom) of "Intermediate" methylation CpGs (left) and sites covered by Illumina's Infinium Methylation EPIC (850K, middle) and TruSeq Methyl Capture EPIC (right). Chr, chromosome; TSS, transcriptional start site; TTS, transcriptional termination site; UTR, untranslated region.
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The standard deviation of DNA methylation, of individual sites captured by our human sperm panel, was calculated from libraries (a minimum of 20x coverage, sequenced in at least 30 of 45 individuals). The average variation from "Intermediate" methylation (n=571,584) and 850K derived (n=1,040,764) sites was determined and plotted. Similarly, the average variation from five different sets of randomly chosen 850K derived sites (R1-R5 850K), where a similar number as "Intermediate" methylation sites was selected, was also plotted. Mean + SD; Unpaired t-test between "Intermediate" and 850K, **** p<0.001; ANOVA between "Intermediate " and random (R1-R5 850K) data, **** p<0.001. All CpG sites targeted by our human sperm capture panel, as well as DMCs found to be altered due to MTHFR genotype and by high-dose folic acid supplementation (in both MTHFR 677CC and 677TT groups) were overlapped with functional or sensitive areas in the human genome. The percentage enrichment for sites found overlapping with histone retention sites of A) H3K4me1, B) H3K4me3, C) H3K27ac, and D) H3K27me3, as well as with E) evolutionarily conserved elements, F) conserved sperm DNA methylation patterns and G) sites of altered methylation due to dioxin exposures were analysed. H) The overlap between DMCs discovered through the different folate metabolism exposures was also assessed. MTHFR, methylenetetrahydrofolate reductase; DMCs, differentially methylated cytosines. Figure S3 . Analysis of DNA methylation variation of different CpG sites captured by the human sperm capture panel. The standard deviation of DNA methylation, of individual sites captured by our human sperm panel, was calculated from libraries (a minimum of 20x coverage, sequenced in at least 30 of 45 individuals). The average variation from "Intermediate" methylation (n=571,584) and 850K derived (n=1,040,764) sites was determined and plotted. Similarly, the average variation from five different sets of randomly chosen 850K derived sites (R1--R5 850K), where a similar number as "Intermediate" methylation sites was selected, was also plotted. Mean + SD; Unpaired t--test between "Intermediate" and 850K, **** p<0.001; ANOVA between "Intermediate " and random (R1--R5 850K) data, **** p<0.001. C) The re--analysis of the RRBS data (Aarabi, M. 2015) using generalized linear regression models to identify differentially methylated cytosines. Gene Ontology analysis for enrichments of biological processes was performed with DMCs within genic regions from subjects of D) 677CC and E) 677TT genotypes. MTHFR, methylenetetrahydrofolate reductase; RRBS, reduced representation bisulfite sequencing; DMCs, differentially methylated cytosines. Figure S10. Analysis of folate metabolism--related DMCs with publically available datasets. All CpG sites targeted by our human sperm capture panel, as well as DMCs found to be altered due to MTHFR genotype and by high--dose folic acid supplementation (in both MTHFR 677CC and 677TT groups) were overlapped with functional or sensitive areas in the human genome. The percentage enrichment for sites found overlapping with histone retention sites of A) H3K4me1, B) H3K4me3, C) H3K27ac, and D) H3K27me3, as well as with E) evolutionarily conserved elements, F) conserved sperm DNA methylation patterns and G) sites of altered methylation due to dioxin exposures were analysed. H) The overlap between DMCs discovered through the different folate metabolism exposures was also assessed. MTHFR, methylenetetrahydrofolate reductase; DMCs, differentially methylated cytosines
